DGPPN 2018 Programm

POSTER PRESENTATIONS 305 WEDNESDAY THURSDAY FRIDAY SATURDAY 009 Individualised assessment of efficacy and prediction of outcomes of treatment with Cerebrolysin by machine learning: a new design of the controlled before-and-after study Vitalij Kazin, Kaufbeuren (Germany) Alexandr Merkin, Igor Nikiforov, Andrew Storokha, Igor Dorovskikh, William Caicedo, Georgy Kostiuk, Dmitry Savelyev, Nikola Kasabov, Valery Feigin 010 Approaching therapy of Alzheimer's disease via antidiabetic drug liraglu- tide – hippocampal neurogenesis and cerebral energy metabolism-related gene expression in an experimental rat model of sporadic Alzheimer's Michael Jürgen Hosch, Würzburg (Germany) Ana Knezovic, Sandy Popp, Gabriela Ortega y Schulte, Catharina Hamann, Jelena Osmanovic-Barilar, Emanuela Corradino, Melita Salkovic-Petrisic, Angelika Schmitt- Böhrer 011 Chronic 9-Tetrahydrocannabinol treatment rescues behavior deficits in the 5XFAD familial Alzheimer's mouse model Jannek Moritz Wagner, Göttingen (Germany) Eva Maria Schleicher, Jens Wiltfang, Thomas A. Bayer, Yvonne Bouter 012 Individual vs. health-related qual- ity of life in patients with idiopathic Parkinson's disease, measured with the Schedule for Evaluation of Individual Quality of Life and Parkinson's disease questionnaire Karolina Nowak, Basel (Switzerland) Antonia Meyer, Ivana Handabaka, Peter Fuhr, Ute Gschwandtner P-23 (e) Posters Presentation 13:30– 15:00 h | Hall Helsinki 1 /2 TOPIC 2: Mental disorders due to psycho- tropic substances, behavioural addictions, F1 Addictive disorders Chair: Norbert Wodarz, Regensburg (Germany) 001 The relationship between neuro- physiological correlates of inhibitory control and disorder severity in patients with alcohol use disorders – preliminary results Hallie Batschelet, Bern (Switzerland) Raphaela Martina Tschümperlin, Franz Moggi, Leila Soravia, Thomas König, Susanne Rösner, Anne Keller, Alexander Wopfner, Maria Stein 002 Differences in inhibition between female and male patients with alcohol use disorders – preliminary results Raphaela Martina Tschümperlin, Bern (Switzerland) Hallie Batschelet, Franz Moggi, Thomas König, Susanne Rösner, Anne Keller, Alexander Wopfner, Leila Soravia, Maria Stein 003 Risk factors of addictive behavior formation in young people in Belarusian population Sergey Igumnov, Minsk (Belarus) K. Zbarousky, P. Lapanau 004 Emotional abuse experience is asso- ciated with emotion regulation deficits in substance abuse patients Elisa Stein, Berlin (Germany) Christina Maria Koch, Peter Neu 005 New BDNF mimetic with antidepres- sant-like activity induce prominent atten- uation of opiate withdrawal indices and long-standing analgesia: an experimental study Mark Konstantinopolsky, Moscow (Russia) Larisa Kolik, Tatiana Gudasheva 006 Substance abuse in older adults Karen Reimers, Minneapolis (USA) 007 Neurophysiological correlates of context-dependent inhibition in alcohol use disorder Maria Stein, Bern (Switzerland) Werner Fey, Leonie Steiner, Andrea Federspiel, Thomas König, Franz Moggi